The UK is leading the way in tackling this global health challenge. The Dementia Discovery Fund was created by the UK Department of Health and Alzheimer’s Research UK, alongside six major global pharmaceutical companies to boost innovation in research and development. Cambridge based Gen2 is its first UK investment.